Clexio Biosciences
Manufacturing · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Northern High-Tech Park 10 Hakidma, Yokn...Website
www.clexio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Clexio Biosciences
Clexio Biosciences is a clinical-stage company focused on developing innovative drugs and technologies for patients with Central Nervous System disorders, particularly Major Depressive Disorder (MDD) and Epilepsy. Their lead drug candidate, CLE-100, is currently undergoing Phase 2 clinical trials in the United States, while a second candidate, CLE-043, is in preclinical development. The company aims to address the unmet needs of patients who have not responded to existing treatments. Clexio's multi-asset pipeline reflects their commitment to advancing novel therapies in neuropsychiatry.Explore more
Clexio Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Clexio Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Clexio Biosciences recently announced quarterly report
Check if Clexio Biosciences has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Clexio Biosciences has new funding data
Congratulate Masked Content for being promoted to Masked Content at Clexio Biosciences
Clexio Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Clexio Biosciences had a recent Job posting/layoffs
Product Launch: Get notified when Clexio Biosciences launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if Clexio Biosciences is spiking on competitors!
Recommended Actions
Find VP level buyers at Clexio Biosciences
Find 3 more new buyers
Company Profile Activity
Activity Insights
Clexio Biosciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Clexio Biosciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Clexio Biosciences.
Clexio Biosciences Tech Stack
A closer look at the technologies used by Clexio Biosciences
Clexio Biosciences News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Clexio Biosciences
Sign Up For FreeTo access detailed company insights
Clexio Biosciences is a clinical-stage company focused on developing innovative drugs and technologies for patients with Central Nervous System disorders, particularly Major Depressive Disorder (MDD) and Epilepsy. Their lead drug candidate, CLE-100, is currently undergoing Phase 2 clinical trials in the United States, while a second candidate, CLE-... Read More
